STOCK TITAN

Incyte to Present at Upcoming Investor Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Incyte, a biopharmaceutical company based in Wilmington, Delaware, announced its participation in the Cowen 43rd Annual Health Care Conference. The event is scheduled for March 6, 2023, at 11:10 a.m. (EST) in Boston. The presentation will be available via live webcast on Investor.Incyte.com, with a replay option available for 30 days post-event. Incyte is dedicated to developing proprietary therapeutics addressing serious unmet medical needs. For more details, visit Incyte.com.

Positive
  • None.
Negative
  • None.

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (Nasdaq:INCY) announced today that it will present at the Cowen 43rd Annual Health Care Conference on Monday, March 6, 2023 at 11:10 a.m. (EST) in Boston.

The presentation will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte

Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

Incyte

Media

Catalina Loveman

+1 302 498 6171

cloveman@incyte.com



Investors

Christine Chiou

+1 302 274 4773

cchiou@incyte.com

Source: Incyte

FAQ

When is Incyte presenting at the Cowen 43rd Annual Health Care Conference?

Incyte will present on March 6, 2023, at 11:10 a.m. (EST).

Where can I watch Incyte's presentation at the conference?

The presentation will be available via live webcast on Investor.Incyte.com.

Will Incyte's conference presentation be available for replay?

Yes, the presentation will be available for replay for 30 days after the event.

What is Incyte's focus as a biopharmaceutical company?

Incyte focuses on discovering, developing, and commercializing proprietary therapeutics for serious unmet medical needs.

What is Incyte's stock symbol?

Incyte's stock symbol is INCY.

Incyte Genomics Inc

NASDAQ:INCY

INCY Rankings

INCY Latest News

INCY Stock Data

13.56B
188.30M
2.04%
97.86%
3.85%
Biotechnology
Services-commercial Physical & Biological Research
Link
United States of America
WILMINGTON